Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH)

Forensic Science International

Volumn 212, Issue 1-3, 2011, Pages 247-251

  Holland, Michael G ^a,b,e,f   Schwope, David M ^c   Stoppacher, Robert ^a,d   Gillen, Shane B ^d   Huestis, Marilyn A ^c  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b Upstate New York Poison Center   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d Onondaga County Medical Examiner's Office   (United States)

^e SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^f The Medical Center at Wilton   (United States)

Author keywords

Cannabinoids; Cannabis; Marijuana; Postmortem redistribution; Tetrahydrocannabinol; THC

Indexed keywords

11 HYDROXYDRONABINOL; CANNABIS; DELTA9(11) TETRAHYDROCANNABINOL; TETRAHYDROCANNABINOLIC ACID;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD VOLUME; CADAVER; DRIVING ABILITY; FATALITY; FEMALE; FORENSIC TOXICOLOGY; HUMAN; IMMUNOASSAY; MALE; MASS FRAGMENTOGRAPHY; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; TRAFFIC ACCIDENT;

EID: 80052306847     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2011.06.028     Document Type: Article

References (29)

1. Pounder D.J., Jones G.R. Post-mortem drug redistribution - a toxicological nightmare. Forensic Sci. Int. 1990, 45:253-263.
2. Drummer O.H. Postmortem toxicology of drugs of abuse. Forensic Sci. Int. 2004, 142:101-113.
3. Leikin J.B., Watson W.A. Post-mortem toxicology: what the dead can and cannot tell us. J. Toxicol. Clin. Toxicol. 2003, 41:47-56.
4. Yarema M.C., Becker C.E. Key concepts in postmortem drug redistribution. Clin. Toxicol. (Phila.) 2005, 43:235-241.
5. Pelissier-Alicot A.L., Gaulier J.M., Champsaur P., Marquet P. Mechanisms underlying postmortem redistribution of drugs: a review. J. Anal. Toxicol. 2003, 27:533-544.
6. Prouty R.W., Anderson W.H. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J. Forensic Sci. 1990, 35:243-270.
7. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man 2008, Biomedical Publications, Foster City, CA. Eighth ed.
8. Wishart D.S., Knox C., Guo A.C., Cheng D., Shrivastava S., Tzur D., et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008, 36:D901-D906.
9. Karch S.B. Karch's Pathology of Drug Abuse 2009, CRC Press, Boca Raton, FL. fourth ed.
10. Brunet B., Hauet T., Hebrard W., Papet Y., Mauco G., Mura P. Postmortem redistribution of THC in the pig. Int. J. Legal Med. 2010, 124:543-549.
11. Hilberg T., Rogde S., Morland J. Postmortem drug redistribution - human cases related to results in experimental animals. J. Forensic Sci. 1999, 44:3-9.
12. Raes E., Verstraete A.G. Usefulness of roadside urine drug screening in drivers suspected of driving under the influence of drugs (DUID). J. Anal. Toxicol. 2005, 29:632-636.
13. Gonzalez-Wilhelm L. Prevalence of alcohol and illicit drugs in blood specimens from drivers involved in traffic law offenses. Systematic review of cross-sectional studies. Traffic Inj. Prev. 2007, 8:189-198.
14. Karschner E.L., Schwilke E.W., Lowe R.H., Darwin W.D., Pope H.G., Herning R., et al. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users?. Addiction 2009, 104:2041-2048.
15. Khiabani H.Z., Bramness J.G., Bjorneboe A., Morland J. Relationship between THC concentration in blood and impairment in apprehended drivers. Traffic Inj. Prev. 2006, 7:111-116.
16. Papafotiou K., Carter J.D., Stough C. The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood. Forensic Sci. Int. 2005, 155:172-178.
17. Schwilke E.W., Karschner E.L., Lowe R.H., Gordon A.M., Cadet J.L., Herning R.I., et al. Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clin. Chem. 2009, 55:1188-1195.
18. Flanagan R.J., Connally G., Evans J.M. Analytical toxicology: guidelines for sample collection postmortem. Toxicol. Rev. 2005, 24:63-71.
19. Cook D.S., Braithwaite R.A., Hale K.A. Estimating antemortem drug concentrations from postmortem blood samples: the influence of postmortem redistribution. J. Clin. Pathol. 2000, 53:282-285.
20. Huestis M.A., Henningfield J.E., Cone E.J. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J. Anal. Toxicol. 1992, 16:276-282.
21. Huestis M.A., Henningfield J.E., Cone E.J. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH). J. Anal. Toxicol. 1992, 16:283-290.
22. Skopp G., Potsch L. Stability of 11-nor-delta(9)-carboxy-tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry. Clin. Chem. 2002, 48:301-306.
23. McCurdy H.H., Callahan L.S., Williams R.D. Studies on the stability and detection of cocaine, benzoylecgonine, and 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid in whole blood using Abuscreen radioimmunoassay. J. Forensic Sci. 1989, 34:858-870.
24. Heishman S.J., Huestis M.A., Henningfield J.E., Cone E.J. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol. Biochem. Behav. 1990, 37:561-565.
25. Huestis M.A., Elsohly M., Nebro W., Barnes A., Gustafson R.A., Smith M.L. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations. Ther. Drug Monit. 2006, 28:540-544.
26. Huestis M.A. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol. Handb. Exp. Pharmacol. 2005, 657-690.
27. Huestis M.A., Barnes A., Smith M.L. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations. Clin. Chem. 2005, 51:2289-2295.
28. Giroud C., Menetrey A., Augsburger M., Buclin T., Sanchez-Mazas P., Mangin P. Delta(9)-THC 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people. Forensic Sci. Int. 2001, 123:159-164.
29. Musshoff F., Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther. Drug Monit. 2006, 28:155-163.